Vascular dementia. Differential diagnosis and therapeutic issues

Annales de Medecine Interne

Volumn 149, Issue 4, 1998, Pages 202-208

  Gold, Gabriel ^a,c   Giannakopoulos, Panteleimon ^a   Seux, Anne Laure ^b   Zekry, Dina ^a   Michel, Jean Pierre ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b Paris Descartes University   (France)

^c Hôpital Broca   (Switzerland)

Author keywords

Clinical criteria; Risk factors; Therapy; Vascular dementia

Indexed keywords

AGED; ALZHEIMER DISEASE; ATHEROSCLEROSIS; BRAIN BLOOD FLOW; CARDIOVASCULAR RISK; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; HUMAN; HYPERTENSION; MULTIINFARCT DEMENTIA; REVIEW; RISK FACTOR; STROKE;

AGED; BRAIN; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 0031829191     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. ALZHEIMER A: Die arteriosklertische Atrophie des Gehirns. Allg Zeitschr Psychiatr, 1995; 51: 1809-12
2. TOMLINSON BE, BLESSED G, ROTH M: Observations on the brains of non-demented old people. J Neurol Sci, 1968; 7: 331-56.
3. HACHINSKI VD, LASSEN NA, MARSHALL J: Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet, 1974; 2: 207-10.
4. GORELICK PB, FREELS S, HARRIS DOLLEAR BS, BILLINGSLEY BA, BROWN N: Epidemiology of vascular and Alzheimer's dementia among African Americans in Chicago, IL. Neurology, 1994; 44: 1391-6.
5. ROCKWOOD K, EBLY E, HACHINSKI V, HOGAN D: Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol, 1997; 54: 33-9.
6. MEYER JS, MCCLINTIC K, ROGERS RL, SIMS P, MORTEL K: Aetiological considerations and risk factors for multi-infarct dementia. J Neurol Neurosurg Psychiatr, 1988; 51: 1489-97.
7. SKOOG I, LERNFELT B, et al.: 15-Year longitudinal study of blood pressure and dementia. Lancet, 1996; 347: 1141-4.
8. BABIKIAN U, ROPPER AH: Binswanger's disease: a review. Stroke, 1987; 18: 2-12.
9. LINDSAY J, HEBERT R, ROCKWOOD K: The Canadian Study of Health and Aging. Risk factors for vascular dementia. Stroke, 1997; 28: 526-30.
10. YOSHITAKE T, KIYOHARA Y, KATO I, et al.: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama study. Neurology, 1995; 45: 1161-8.
11. ROGERS RL, MEYER JS, MORTEL KF, MAHURIN RK, JUDD BW: Decreased cerebral blood flow precedes multi-infarct dementia but follows senile dementia of Alzheimer type. Neurology, 1986; 36: 1-6.
12. ROCCA WA, HOFMAN A, BRAYNE C, et al.: The prevalence of vascular dementia in Europe: Facts and fragment from 1980-1990 studies. Ann Neurol, 1991; 30: 817-24.
13. UEDA K, KAWANO H, HASUO Y, FUHISJIMA M: Prevalence and etiology of dementia in a Japanese community. Stroke, 1992; 23: 798-803.
14. KOTSORIS H, BARCLAY LL, KHEYFERTS S, HULYALKAR A, DOUGHERTY J: Urinary and gait disturbances as markers for early multi-infarct dementia. J Neurol Neurosurg Psychiatr, 1988; 1: 138-41.
15. RATCLIFFE PJ, WILCOCK GK: Cerebrovascular disease in dementia: the importance of atrial fibrillation. Postgrad Med J, 1985; 61: 201-4.
16. VAN DUIJN CM, HOFMAN A: Relation between nicotine intake and Alzheimer's disease. BMJ, 1991; 302: 1491-4.
17. BRENNER DE, KUKULL WA, VAN BELLE G, et al.: Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology, 1993; 43: 293-300.
18. KOKMEN E, BEARD CM, CHANDRA V, OFFORD KP, SCHOENBERG BS, BALLARD DJ: Clinical risk factors for Alzheimer's disease: A population based case-control study. Neurology, 1991; 41: 1393-7.
19. LANDIN K, BLENNOW K, WALLIN A, GOTTFRIES C: Low blood pressure and blood glucose levels in Alzheimer's disease: Evidence for a hypometabolic disorder? J Intern Med, 1993; 233: 357-62.
20. MCKANN G, DRACHMAN DA, FOLSTEIN M, KATZMAN R, PRICE D, STADLAN EM: Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 1984; 34: 939-44.
21. PRINCE MJ, CULLEN MC, MANN A: Risk factors for Alzheimer's disease and dementia: A case-control study based on the MRC elderly hypertension trial. Neurology, 1994; 4: 97-104.
22. GUO Z, VIITANEN M, FRATIGLIONI L, WINBLAD B: Low blood pressure and dementia in elderly people the Kungsholmen project. BMJ, 1996; 312: 805-8.
23. TATEMICHI TK, DESMOND DW, MAYEUX R, et al.: Dementia after stroke: baseline frequency, risks and clinical features in a hospitalized cohort. Neurology. 1992; 42: 1185-93.
24. ANDERSEN G, VESTERGAARD K, OSTERGAARD RIIS J, INGEMAN-NIELSEN M. Intellectual impairment in the first year following stroke, compared to an age-matched population sample. Cerebrovasc Dis, 1996; 6: 363-9.
25. KOKMEN E, WHISNANT JP, O'FALLON WM, CHU CP, BEARD CM: Dementia after ischemic stroke: a popultion-based study in Rochester, Minnesota (1960-1984). Neurology, 1996; 19: 154-9.
26. TATEMICHI TK, PAIK M, BAGIELLA E, et al.: Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology, 1994; 44: 1885-91.
27. GORELICK PB, BRODY J, COHEN D, et al.: Risk factors for dementia associated with multiple cerebral infarcts. A case-control analysis in predominantly African-American hospital-based patients. Arch Neurol, 1993; 50: 714-20.
28. SKOOG I: Risk factors for vascular dementia: a review. Dementia, 1994; 5: 137-44.
29. HÉBERT R, BRAYNE C: Epidemiology of vascular dementia. Neuroepidemiology, 1995; 14: 240-57.
30. MORTEL KF, MEYER JS, HEROD B, THORNBY J: Education and occupation as risk factors for dementia of the Alzheimer and ischemic vascular types. Dementia, 1995; 6: 55-62.
31. PRENCIPE M, FERRETTI C, CASINI AR, SANTINI M, GIUBILEI F, CULASSO F: Stroke and dementia: results of a population survey. Stroke, 1997; 28: 531-6.
32. POHJASVAARA T, ERKINJUNTTI T, YLIKOSKI R, HIETANEN M, VATAJA R, KASTE M: Clinical determinants of poststroke dementia. Stroke, 1998; 29: 75-81.
33. VERHEY FRJ, LODDER J, ROZENDAAL N, JOLLES J: Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology, 1996; 15: 166-72.
34. PANTONI L, INZITARI D: Hachinski's ischemic score and the diagnosis of vascular dementia: a review. Ital J Neurol Sci, 1993; 14: 539-46.
35. LISTON EH, LA RUE A: Clinical differentiation of primary degenerative and multi-infarct dementia: a critical review of the evidence. Part I: clinical studies. Biol Psychiatry, 1983; 18: 1451-65.
36. LISTON EH, LA RUE A: Clinical differentiation of primary degenerative and multi-infarct dementia: a critical review of the evidence. Part II: pathological studies. Biol Psychiatr, 1983; 18: 1467-84.
37. GOLD G, GIANNAKOPOULOS P, MONTES-PAIXAO C, et al.: Sensitivity and specificity of newly proposed criteria for the diagnosis of possible vascular dementia. Neurology, 1997; 49: 690-4.
38. MORONEY JT, BAGIELLA E, DESMOND DW, et al.: Meta-analysis of the Hachinski ischemic score in pathologically verified dementias. Neurology, 1997; 49: 1096-105.
39. ROSEN WG, TERRY RD, FULD PA, KATZMAN R, PECK A: Pathological verification of ischemic score in differentiation of dementias. Ann Neurol, 1980; 7: 486-8.
40. LOEB C, GANDOLFO C: Diagnostic evaluation of degenerative and vascular dementia. Stroke, 1983; 14: 399-401.
41. WORLD HEALTH ORGANIZATION. The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. Geneva, Switzerland: World Health Oganization, 1992; 50-1.
42. American Psychiatric Association Diagnostic and Statistical Manual of Mental disorders, ed 4. Washington: American Psychiatric Association, 1994.
43. WETTERLING T, DANITZ RD and BORGIS KJ: The ICD-10 Criteria for Vascular Dementia. Dementia, 1994; 5185-8.
44. ERKINJUNTTI T, OSTBYE T, STEENHUIS R, HACHINSKI V: The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med. 1997; 337: 1667-74.
45. CHUI HC, VICTOROFF JI, MARGOLIN D, JAGUST W, SHANKLE R, KATZMAN R: Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology, 1992; 42: 473-80.
46. ROMAN GC, TATEMICHI TK, ERKINJUNTTI T, et al.: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 1993; 43: 250-9.
47. AMAR K, WILCOCK GK, SCOTT M: The diagnosis of vascular dementia in the light of the new criteria. Age Ageing, 1996; 25: 51-5.
48. FORNARELLI D, ASCOLI G, ROSSI R, et al.: Clinical and instrumental diagnosis of Alzheimer's and multi-infarct dementia. Radiol Med. 1996; 92: 22-7.
49. LOEB C, MEYER JS: Vascular dementia: still a debatable entity? J Neurol Sci, 1996; 143: 31-40.
50. MEYER JS, SHIRAI T, AKIYAMA H: Neuroimaging for differentiating vascular from Alzheimer's dementias. Cerebrovasc Brain Metab Rev. 1996; 8: 1-10.
51. FRISONI GB, BELTRAMELLO A, BINETTI G, et al.: Computed tomography in the detection of the vascular component in dementia. Gerontology, 1995; 41: 121-8.
52. CHARLETTA D, GORELICK PB, DOLLEAR TJ, FREELS S, HARRIS Y: CT and MRI findings among African-Americans with Alzheimer's disease, vascular dementia, and stroke without dementia. Neurology, 1995; 45: 1456-61.
53. PULLICINO P, BENEDICT RH, CAPRUSO DX, VELLA N, WITHIAM-LEITCH S, KWEN PL: Neuroimaging criteria for vascular dementia. Arch Neurol, 1996; 53: 723-8.
54. SCHMIDT R: Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging. Eur Neurol, 1992; 2: 164-9.
55. SKOOG I, PALMERTZ B, ANDREASSON LA: The prevalence of white matter lesions on computed tomography of the brain in demented and nondemented 85-year olds. J Geriatr Psychiatr Neurol, 1994; 7: 169-75.
56. O'BRIEN J, DESMOND P, AMES D, SCHWEITZER I, HARRIGAN S, TRESS B: A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease. Br J Psychiatr, 1996; 168: 477-85.
57. BENNETT DA, GILLEY DW, LEE S, COCHRAN EJ: White matter changes: neurobehavioral manifestations of Binswanger's disease and clinical correlates in Akheimer's disease. Dementia, 1994; 5: 148-52.
58. MEYER JS, KAWAMURA J, TERAYAMA Y: White matter lesions in the elderly. J Neurol Sci, 1992; 10: 1-7.
59. LECHNER H, NIEDERKORN K, SCHMIDT R: Does cerebrovascular insufficiency contribute to Alzheimer's disease? Ann N Y Acad Sci, 1991; 640: 74-9.
60. OBARA K, MEYER JS, MORTEL KF, MURAMATSU K: Cognitive declines correlated with decreased cortical volume and perfusion in dementia of Alzheimer's type. J Neurol Sci. 1994; 127: 96-102.
61. MEYER JS, OBARA K, MURAMATSU K, MORTEL KF, SHIRAI T: Cognitive performance after small strokes correlates with ischemia not atrophy of the brain. Dementia, 1995; 6: 312-22.
62. EBERLING JL, JAGUST WJ, REED BR, BAKER MG: Reduced temporal lobe blood flow in Alzheimer's disease. Neurobiol Aging, 1992; 13: 483-91.
63. HARRIS GJ, LEWIS RF, SATLIN A, et al.: Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease. Am J Psychiatr, 1996; 153: 721-4.
64. WOLFE N, REED BR, EBERLING JL, JAGUST WJ: Temporal lobe perfusion on single photon emission tomography predicts the rate of cognitive decline in Alzheimer's disease. Arch Neurol. 1995; 52: 257-62.
65. JOHANSSON B: Vascular mechanisms in hypertensive cerebrovascular disease. J Cardiovasc Pharmacol, 1992; 19: S11-S15.
66. 2 reactivity in the rat. Gerontology, 1995; 41: 11-7.
67. JUDD BW, MEYER JS, ROGERS RL, et al.: Cognitive performance correlates with cerebrovascular impairments in multi-infarct dementia. J Am Geriatr Soc, 1986; 34: 355-60.
68. DEUTSCH G, TWEEDY JR: Cerebral blood flow in severity matched Alzheimer and multi-infarct patients. Neurology, 1987; 37: 431-8.
69. MIELKE R, PIETRZYK U, JACOBS A, et al.: HMPAO SPECT and PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. Eur J Nucl Med, 1994; 21: 1052-60.
70. STARKSTEIN SE, SABE L, VAZQUEZ S, et al.: Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke, 1996; 27: 408-14.
71. MASTERMAN DL, MENDEZ MF, FAIRBANKS LA, CUMMINGS JL: Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias. J Geriatr Psychiatr Neurol, 1997; 10: 15-21.
72. DE LEON MJ, FERRIS SH, GEORGE AE, et al.: Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease. J Cereb Bloof Flow Metab, 1983; 3: 391-4.
73. MCGEER PL, KAMO H, HARROP P, et al.: Comparison of PET, MRI and CT with pathology in a proven case of Alzheimer's disease. Neurology, 1986; 36: 1569-74.
74. SMITH GS, DE LEON MJ, GEORGE AE, et al.: Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Arch Neurol, 1992; 49: 1142-50.
75. Rapport SI: Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review. Cerebrovasc Brain Metab Rev, 1991; 3: 297-335.
76. POLINSKY RJ, NOBLE H, DICHIRO G: Dominantly inherited Alzheimer's disease: cerebral glucose metabolism. J Neurol Neurosurg Psychiatr, 1987; 50: 752-7.
77. JAGUST WJ, FRIEDLAND RP, BUDINGER TF: Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology, 1988; 38: 909-12.
78. JAGUST WJ, EBERLING JL, RICHARDSON BC, et al.: The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease. Brain Res. 1993; 629: 189-98.
79. MIELKE R, SCHRODER R, FINK GR, KESSLER J, HERHOLZ K, HEISS WD: Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathol. 1996; 91: 174-9.
80. FRACKOWIAK RSJ, POZZILLI C, LEGG NJ, et al.: Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain, 1981; 104: 753-78.
81. HOYER S: Senile dementia and Alzheimer's disease, brain blood flow and metabolism. Prog Neuro-Psychopharmacol Biol Psychiatry, 1986; 10: 447-78.
82. HERHOLZ K: FDG PET and differential diagnosis of dementia. Alzheimer Dis Assoc Disord, 1995; 9: 6-16.
83. HEISS WD, KESSLER J, SZELIES B, GROND M, FINK G, HERHOLZ K: Positron emission tomography in the differential diagnosis of organic dementias. J Neural Transm Suppl, 1991; 33: 13-9.
84. SHEP COOPERATIVE RESEARCH GROUP: Prevention of stroke by antihypertensive drug treatement in older persons with isolated systolic hypertension. JAMA, 1991; 265: 3225-64.
85. STAESSEN JA, FAGARD R, THIJS L, et al.: Randomized double-blind comparison of placebo and active treatment of older patients with isolated systolic hypertension. Lancet, 1997; 350: 757-64.
86. MEYER JS, ROGERS RL, MCCLINTIC K, MORTEL KF, LOTFI J: Randomized clinical trial of daily aspirin therapy in multi-infarct dementia.: a pilot study. J Am Geriatr Soc, 1989; 37: 549-55.
87. PANTONI L, CAROSI M, AMIGONI S, MASCALCHI M, INZITARI D: A preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis. Clin Neuropharmacol, 1996; 19: 491-506.
88. SALETU B, PAULUS E, LINZMAYER L, et al.: Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-bind, placebo-controlled, clinical and EEG/ERP mapping study. Psychopharmacology, 1995; 117: 385-95.
89. BLACK RS, BARCLAY LL, NOLAN KA, THALER HT, HARDIMAN ST, BLASS JP: Pentoxifylline in cerebrovascular dementia. J Am Geriatr Soc, 1992; 40: 237-44.
90. European Pentoxifylline Multi-infarct Dementia Study. Eur Neurol, 1996; 36: 315-21.
91. HUBER M, KITTNER B, HOJER C, FINK GR, NEVELING M, HEISS WD: Effect of propentofylline on regional cerebral glucose metabolism in acute ischemic stroke. J Cereb Blood Flow Metab, 1993; 13: 526-30.
92. KITTNER B, ROSSNER M, ROTHER M: Clinical trials in dementia with propentofylline. Ann N Y Acad Sci, 1997; 826: 307-16.
93. MARCUSSON J, ROTHER M, KITTNER B, et al.: A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group. Dement Geriatr Cogn Disord, 1997; 8: 320-8.
94. LE BARS PL, KATZ MM, BERMAN N, ITIL T, FREEDMAN A, SCHATZBERG: A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia. JAMA, 1997; 278: 1327-32.